You are here

News & Events

Institute News
Melbourne, Australia: Pioneering allergy immunotherapy company Prota Therapeutics Pty Ltd (Prota) is pleased to announce full enrolment to the multicentre Phase 2b clinical trial investigating the effectiveness of its Probiotic and Peanut Oral Immunotherapy (PPOIT) treatment licensed from the Murdoch Children’s Research Institute (MCRI).
Institute News
Victorian Clinical Genetics Services (VCGS) welcomes the $500M allocation to investment in genomic research as part of the federal budget 2018. The first research project ‘Mackenzie’s Mission’ is a $20M trial into pre-conception genetic carrier screening for serious genetic conditions like cystic fibrosis, spinal muscular atrophy and fragile X syndrome.
Institute News
The 11th International Symp​o​sium​​ on Pneumococci and Pneumococc​al Diseases (ISPPD) has begun! Over 1100 researchers from all around the world have gathered in Melbourne for the event, which aims to bring together professionals in the field to raise global awareness and improve standards of diagnosis, prevention and treatment of pneumococci and pneumococc​al diseases.